Deskside with Dr. Dan
FDA approves nivolumab and ipilimumab for unresectable malignant pleural mesothelioma
In February 2021, the FDA approved a new treatment combination for unresectable malignant pleural mesothelioma patients and Gryt Health’s Chief Medical Officer, Dr. Dan breaks it down for us.
Gryt Health
September 29, 2022
